Steven L. Hoerter
CIK 1533451 · President and CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.46M
Companies
8
Total Filings
72
Lifetime Open-Market Net
-$9.16M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MBX | Director | 31,938 | $35.51 | $1.13M | $265.0K | 9 | 2026-06-05 |
| ORIC | Director | — | $8.27 | — | $0 | 6 | 2026-01-06 |
| CCCC | Director | — | $3.90 | — | $0 | 2 | 2025-06-20 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | President and CEO | 72,763 | $25.59 | $1.86M | -$1.33M | 21 | 2024-06-11 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | — | $33.99 | — | $0 | 4 | 2021-06-04 |
| AGIO | Chief Commercial Officer | 10,941 | $29.46 | $322.3K | -$3.75M | 16 | 2019-03-05 |
| Ignyta, Inc. (RXDX) Delisted | Director | — | $199.92 | — | $0 | 2 | 2017-06-19 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 0 | $0.08 | $0 | -$4.34M | 9 | 2015-03-09 |
Recent Filings · Page 4 of 8
72 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-18 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-25 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Exer (M) | +1,078 | $27.4K | EDGAR |
| 2020-08-24 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Exer (M) | +187 | $4.7K | EDGAR |
| 2020-07-22 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Exer (M) | +188 | $4.8K | EDGAR |
| 2020-06-19 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +187 | $4.7K | EDGAR |
| 2020-06-08 | CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-01 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +188 | $4.8K | EDGAR |
| 2020-04-23 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | +187 | $4.7K | EDGAR |
| 2020-03-20 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Mixed | −10,170 | -$408.5K | EDGAR |
| 2020-02-20 | Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.